M&A Deal Summary

Sartorius Stedim Biotech Acquires Danaher - Life Science Portfolio

On October 21, 2019, Sartorius Stedim Biotech acquired life science company Danaher - Life Science Portfolio from Danaher for 750M USD

Acquisition Highlights
  • This is Sartorius Stedim Biotech’s 5th transaction in the Life Science sector.
  • This is Sartorius Stedim Biotech’s 2nd largest (disclosed) transaction.
  • This is Sartorius Stedim Biotech’s 6th transaction in the United States.
  • This is Sartorius Stedim Biotech’s 1st transaction in District of Columbia.

M&A Deal Summary
Date 2019-10-21
Target Danaher - Life Science Portfolio
Sector Life Science
Buyer(s) Sartorius Stedim Biotech
Sellers(s) Danaher
Deal Type Divestiture
Deal Value 750M USD

Target

Danaher - Life Science Portfolio

Washington, District of Columbia, United States
Danaher Corp's Life Science Portfolio includes chromatography and SoloHill business. The chromatography business addresses an essential step in downstream bioprocessing and encompasses multi-use and single-use equipment as well as columns and resins. The SoloHill business includes mainly a microcarrier technology and particle validation standards used in cell culture and other bioprocesses.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sartorius Stedim Biotech

Aubagne, France
Category Company
Founded 1870
Sector Internet Software and Services
Employees10,493
Revenue 816.0B EUR (2023)
DESCRIPTION

Sartorius Stedim Biotech is a provider of cutting edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry. Sartorius Stedim Biotech was founded in 1870 and is based in Aubagne, France.

DEAL STATS #
Overall 12 of 19
Sector (Life Science) 5 of 11
Type (Divestiture) 3 of 4
State (District of Columbia) 1 of 1
Country (United States) 6 of 7
Year (2019) 1 of 2
Size (of disclosed) 2 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-03 MKS Instruments AB

Malmo, Sweden

MKS Instruments AB (Umetrics) is a provider of data analytics software for modeling and optimizing development and manufacturing processes. SSB has been a cooperation partner of Umetrics since the end of 2012, distributing and co-marketing their software to major players in the biopharmaceutical industry.

Buy $73M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-05 Biological Industries Israel Beit Haemek

Haifa, Israel

Biological Industries Israel Beit Haemek Ltd. focuses on cell culture media, particularly for cell and gene therapy, regenerative medicine and other advanced therapies. Biological Industries Israel Beit Haemek was founded in 1981 and is based in Haifa, Isreal.

Buy €45M

Seller(S) 1

SELLER

Danaher

Washington, District of Columbia, United States
Category Company
Founded 1969
Sector Diversified
Employees79,000
Revenue 23.9B USD (2023)
DESCRIPTION

Danaher designs, manufactures and markets professional, medical, industrial and commercial products and services. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. Danaher's business consists of five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. Danaher was incorporated in 1969 and is based in Washington, District of Columbia.

DEAL STATS #
Overall 9 of 9
Sector (Life Science) 1 of 1
Type (Divestiture) 6 of 6
State (District of Columbia) 1 of 1
Country (United States) 7 of 7
Year (2019) 1 of 1
Size (of disclosed) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-25 GE Biopharma

Pittsburgh, Pennsylvania, United States

GE Biopharma is a provider of instruments, consumables, and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. The business is comprised of process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and service.

Buy $21.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-01 Precision NanoSystems

Vancouver, British Columbia, Canada

Precision NanoSystems provides instruments, reagents, and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology. Precision NanoSystems was founded in 2010 and is based in Vancouver, British Columbia.

Buy -
Mergr

Product

Company

Legal